ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 110 filers reported holding ATARA BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $316,488 | +25.1% | 213,843 | +36.1% | 0.00% | – |
| Q2 2023 | $253,012 | -60.6% | 157,150 | -29.1% | 0.00% | – |
| Q1 2023 | $642,945 | +144.1% | 221,705 | +176.1% | 0.00% | – |
| Q4 2022 | $263,351 | -70.5% | 80,290 | -66.0% | 0.00% | – |
| Q3 2022 | $894,000 | +95.2% | 236,418 | +301.5% | 0.00% | – |
| Q2 2022 | $458,000 | -57.9% | 58,881 | -49.8% | 0.00% | – |
| Q1 2022 | $1,089,000 | -72.8% | 117,264 | -53.8% | 0.00% | – |
| Q4 2021 | $4,000,000 | +115.4% | 253,794 | +144.6% | 0.00% | – |
| Q3 2021 | $1,857,000 | +62.0% | 103,770 | +40.8% | 0.00% | – |
| Q2 2021 | $1,146,000 | +32.3% | 73,684 | +22.1% | 0.00% | – |
| Q1 2021 | $866,000 | -71.8% | 60,323 | -61.4% | 0.00% | – |
| Q4 2020 | $3,070,000 | +52.7% | 156,388 | +0.8% | 0.00% | – |
| Q3 2020 | $2,011,000 | +20.9% | 155,211 | +35.9% | 0.00% | – |
| Q2 2020 | $1,663,000 | +125.0% | 114,222 | +31.7% | 0.00% | – |
| Q1 2020 | $739,000 | -69.6% | 86,746 | -41.2% | 0.00% | – |
| Q4 2019 | $2,429,000 | +17.9% | 147,470 | +1.1% | 0.00% | – |
| Q3 2019 | $2,060,000 | -76.6% | 145,892 | -66.7% | 0.00% | -100.0% |
| Q2 2019 | $8,803,000 | +38.2% | 437,732 | +173.2% | 0.00% | -66.7% |
| Q1 2019 | $6,368,000 | +20.1% | 160,200 | +5.0% | 0.00% | +50.0% |
| Q4 2018 | $5,301,000 | +2.7% | 152,600 | +22.3% | 0.00% | 0.0% |
| Q3 2018 | $5,160,000 | -50.4% | 124,800 | -55.9% | 0.00% | -50.0% |
| Q2 2018 | $10,401,000 | -36.6% | 283,031 | -32.7% | 0.00% | -33.3% |
| Q1 2018 | $16,395,000 | +872.4% | 420,400 | +351.1% | 0.01% | – |
| Q4 2017 | $1,686,000 | +273.0% | 93,200 | +241.4% | 0.00% | – |
| Q3 2017 | $452,000 | -58.9% | 27,300 | -65.3% | 0.00% | – |
| Q2 2017 | $1,101,000 | +41.3% | 78,600 | +107.4% | 0.00% | – |
| Q1 2017 | $779,000 | +198.5% | 37,900 | +105.8% | 0.00% | – |
| Q4 2016 | $261,000 | +22.0% | 18,415 | +127.3% | 0.00% | – |
| Q4 2015 | $214,000 | -77.8% | 8,100 | -73.5% | 0.00% | – |
| Q3 2015 | $962,000 | -29.8% | 30,604 | +17.7% | 0.00% | – |
| Q2 2015 | $1,371,000 | +457.3% | 26,000 | +182.5% | 0.00% | – |
| Q4 2014 | $246,000 | – | 9,202 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XV Associates, LLC | 1,876,650 | $29,576,000 | 23.33% |
| Antipodean Advisors LLC | 1,000,000 | $15,760,000 | 6.47% |
| M28 Capital Management LP | 456,865 | $7,200,000 | 5.62% |
| Redmile Group, LLC | 6,437,777 | $101,459,000 | 2.31% |
| One Fin Capital Management LP | 303,000 | $4,775,000 | 1.99% |
| MAVERICK CAPITAL LTD | 7,855,824 | $123,808,000 | 1.40% |
| Baupost Group | 8,477,488 | $133,605,000 | 1.32% |
| BRIDGER MANAGEMENT, LLC | 616,488 | $9,716,000 | 1.26% |
| 683 Capital Management, LLC | 1,781,234 | $28,073,000 | 1.03% |
| Trellus Management Company, LLC | 95,000 | $1,497,000 | 1.00% |